Castle Biosciences reported cash from operations of $15.20M and free cash flow of $6.55M for the quarter ended Jun 2026, down 27.0% year over year. This cash flow statement covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||||
| Net Income | -11.79M | -13.38M | -24.62M | -1.65M | -20.25M | -20.62M | -29.20M | -18.78M | -6.91M | -2.58M | -2.53M | 8.92M | 2.27M | 9.59M | -25.85M | 4.56M | -0.50M | -2.33M | -14.52M | -2.06M | |||||||||||||
| Share-based CompensationStock Comp. | 5.21M | 6.85M | 8.42M | 8.78M | 9.20M | 9.92M | 13.53M | 12.85M | 13.04M | 11.80M | 12.68M | 13.18M | 13.03M | 11.44M | 11.18M | 11.21M | 12.10M | 11.41M | 9.78M | 11.59M | |||||||||||||
| Deferred Taxes | -8.74M | 0.12M | -1.96M | -0.04M | 0.01M | -0.24M | -1.54M | 5.25M | -2.31M | -0.77M | -4.67M | 0.12M | -0.91M | -0.01M | -0.00M | ||||||||||||||||||
| Gains from Investment SecuritiesGains Investment | 2.56M | -20.40M | -0.15M | -0.30M | |||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -6.13M | -2.78M | -21.43M | -9.00M | -5.22M | -6.00M | -25.44M | -3.79M | 5.01M | 18.59M | -6.83M | 24.00M | 23.34M | 24.36M | -6.04M | 20.82M | 22.63M | 26.93M | -22.13M | 15.20M | |||||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.18M | 1.18M | 1.23M | 1.05M | 1.57M | 1.64M | 1.70M | 1.72M | 1.65M | 1.61M | 1.44M | 1.17M | 0.91M | 0.71M | 0.45M | 0.39M | |||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | |||||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 1.09M | 1.45M | 2.15M | 2.63M | 2.92M | 2.84M | 2.89M | 3.04M | 3.17M | 3.22M | 3.34M | 3.35M | 3.54M | 5.77M | 29.76M | 3.41M | 3.82M | 3.78M | 3.93M | 4.07M | |||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.81M | -1.46M | 2.73M | 2.90M | 0.05M | 0.54M | 4.38M | 3.60M | 5.80M | 1.15M | 4.26M | 3.36M | 4.25M | 0.77M | 5.22M | -3.91M | -1.91M | -6.27M | -1.07M | 5.82M | |||||||||||||
| Change in InventoryChange Inventory | 0.25M | -0.35M | 0.33M | 0.74M | 0.44M | 0.18M | 0.54M | 1.60M | -0.35M | 2.17M | -0.30M | 0.37M | -1.44M | 1.56M | -1.29M | 1.52M | 0.31M | 1.60M | 0.21M | 0.12M | |||||||||||||
| Change in Account PayablesChange Payables | 1.36M | -0.85M | 0.19M | 0.12M | 1.85M | -1.57M | 3.90M | -0.82M | -0.38M | 3.01M | -0.42M | -1.23M | -2.15M | -0.57M | 0.61M | 1.07M | 1.41M | -0.02M | 3.19M | -2.31M | |||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 3.54M | 3.20M | -6.92M | 8.03M | 2.56M | 4.83M | -11.56M | 4.50M | 5.11M | 6.54M | -14.24M | 6.53M | 6.43M | 4.88M | -14.70M | 7.12M | 9.48M | 3.83M | -19.18M | 7.78M | |||||||||||||
| Other Working Capital ChangesOther WC Changes | -3.18M | -3.00M | |||||||||||||||||||||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | -29.70M | 0.40M | 1.41M | 2.04M | 1.79M | 3.34M | 4.04M | 2.46M | 3.79M | 9.15M | 5.23M | 6.38M | 7.57M | 4.74M | 9.26M | 14.83M | 7.18M | 12.46M | 8.65M | ||||||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | 0.00M | 0.00M | 0.01M | 0.00M | 0.19M | 0.01M | 0.00M | 0.00M | 0.00M | 0.01M | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.02M | 0.01M | 0.01M | 0.01M | ||||||||||||||
| Acquisitions | 0.30M | ||||||||||||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 50.00M | 45.00M | 43.00M | 48.50M | 50.20M | 36.25M | 36.80M | 60.65M | 36.30M | 44.00M | 54.90M | 54.00M | 39.10M | 41.00M | |||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.92M | -30.89M | -0.40M | -27.51M | -134.15M | -4.48M | 16.58M | -15.39M | -9.71M | -7.67M | -19.70M | -21.42M | -14.79M | 5.77M | -22.43M | -28.38M | -18.39M | 8.83M | -25.80M | -15.96M | |||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 1.52M | 0.37M | 0.90M | 0.61M | 0.30M | 0.68M | 0.98M | 0.71M | 0.34M | 0.68M | 1.09M | 0.66M | 0.58M | 0.65M | 0.97M | 0.51M | 0.22M | 0.71M | 1.27M | 0.84M | |||||||||||||
| Cash from Financing ActivitiesCash from Financing | 1.89M | 0.13M | 1.22M | 0.66M | 0.39M | -0.75M | 0.73M | 0.23M | 0.04M | -3.30M | 10.64M | 0.04M | 0.84M | -5.38M | -1.55M | 0.10M | -0.92M | -4.59M | -5.03M | -0.89M | |||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | |||||||||||||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||
| Change in Cash | -5.16M | -33.54M | -20.62M | -35.85M | -138.99M | -11.23M | -8.13M | -18.95M | -4.65M | 7.62M | -15.89M | 2.62M | 9.39M | 24.75M | -30.02M | -7.46M | 3.32M | 31.17M | -52.97M | -1.65M | |||||||||||||
| Free Cash FlowFCF | -6.13M | 26.92M | -21.83M | -10.41M | -7.26M | -7.79M | -28.78M | -7.82M | 2.56M | 14.79M | -15.99M | 18.77M | 16.96M | 16.80M | -10.78M | 11.56M | 7.80M | 19.75M | -34.58M | 6.55M | |||||||||||||
| Net Cash FlowNCF | -5.16M | -33.54M | -20.62M | -35.85M | -138.99M | -11.23M | -8.13M | -18.95M | -4.65M | 7.62M | -15.89M | 2.62M | 9.39M | 24.75M | -30.02M | -7.46M | 3.32M | 31.17M | -52.97M | -1.65M |